UK Stocks-Factors to watch on Sept 23

Sept 23 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening 19 points higher on Thursday, with futures .FFIc1 marginally up 0.65%.

* MITCHELLS & BUTLERS: Britain's Mitchells & Butlers Plc MAB.L said sales over the past two months have been above pre-pandemic levels.

* ROYAL MAIL: Royal Mail Plc RMG.L forecast a surge in first-half operating profit, despite warning on higher costs.

* ASTRAZENECA: AstraZeneca Plc AZN.L struck a deal with the firm behind Imperial College London's experimental COVID-19 vaccine to develop and sell drugs based on its self-amplifying RNA technology platform in other disease areas.

* AUGEAN: Investment manager Ancala Partners outbid Morgan Stanley Infrastructure in an auction to buy UK-based waste management firm Augean AUG.L for 390 million pounds, Britain's takeover regulator said on Thursday.

* OFGEM: Britain is having talks with energy regulator Ofgem about whether a cap on gas and electricity prices for consumers may have to go up, junior business minister Paul Scully said on Thursday.

* UK MINISTERS: Britain is trying to solve the shortage of qualified HGV drivers by encouraging former truckers back into the market and speeding up the testing system, because changing visa rules to attract international workers is no panacea, a business minister said.

* GOLD: Gold prices dipped as the dollar strengthened after the U.S. Federal Reserve signalled a withdrawal of its asset purchases by next year and a sooner-than-expected interest rate hike, dimming the appeal of the non-yielding bullion.

* OIL: Oil prices extended gains, riding higher on growing fuel demand and a bigger-than-expected draw in U.S. crude inventories as production remains hampered in Gulf of Mexico.

* London's FTSE 100 recorded its best day in two months on Wednesday.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

(Reporting By Geetha Panchaksharam)

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.